The Oncology Institute, Inc. (TOI)
Nasdaq: TOI · Services-Offices & Clinics of Doctors of Medicine · Cerritos, CA · filing with the SEC since 2020
Filings
266 filings since 2017 beside 283 insider forms · Accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026Due nextAccelerated filer and smaller reporting company
10-K
Annual report for the fiscal year ending Dec 31, 2026Accelerated filers have 75 days after the fiscal year ends.
by Mar 16, 2027
10-Q
Quarterly report for the quarter ending Mar 31, 2027Accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end.
by May 10, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 36 days after the quarter ended. The proxy statement was last filed Apr 30, 2026.
Filings a yearinsider forms included
267714669569976
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 8 times in the last 36 months, the newest Sep 2, 2026.Serious cyber incident (8-K item 1.05): 1 time in the last 36 months, the newest May 22, 2026.Listing warning from its exchange (8-K item 3.01): 2 times in the last 36 months, the newest Dec 19, 2024.SEC letters: 7 in the last 36 months, the newest Jun 16, 2025.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Aug 21, 2026
8-K items 1.01, 2.03, 9.01
Major agreement signed; New debt or obligation taken on · Current report
Aug 20, 2026
Aug 3, 2026
8-K items 5.03, 7.01, 9.01
Charter, bylaw or fiscal-year change; Investor disclosure (Regulation FD) · Current report
Jul 28, 2026
Jul 7, 2026
8-K items 1.01, 2.03, 3.02, 7.01, 9.01
Major agreement signed; New debt or obligation taken on; Shares sold without registration; Investor disclosure (Regulation FD) · Current report
Jul 1, 2026
Feb 23, 2026
8-K items 5.02, 7.01, 9.01
Officer or director change; Investor disclosure (Regulation FD) · Current report
Jan 7, 2026
8-K items 5.02, 7.01, 9.01
Officer or director change; Investor disclosure (Regulation FD) · Current report
Jan 2, 2026
Dec 1, 2025
8-K items 5.02, 7.01, 9.01
Officer or director change; Investor disclosure (Regulation FD) · Current report
Nov 26, 2025
Aug 13, 2025
8-K items 5.02, 7.01, 9.01
Officer or director change; Investor disclosure (Regulation FD) · Current report
Aug 8, 2025
40 of 266 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.